2018
DOI: 10.1016/j.ijbiomac.2018.03.074
|View full text |Cite
|
Sign up to set email alerts
|

The engineered β-lactoglobulin with complementarity to the chlorpromazine chiral conformers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 10 publications
(24 citation statements)
references
References 51 publications
1
22
0
1
Order By: Relevance
“…At least one nanomaterial-based biosensor exists for organophosphorus pesticides, using acetylcholinesterase and gold nanoparticles [37]. BLG is amenable to nanoparticle formation [38], as well as to reengineering to bind selected ligands, such as a dopamine antagonist [39]. BLG has the additional property of being able to bind different ligands with good affinity with a single binding site, which can be exploited in biosensor design.…”
Section: Discussionmentioning
confidence: 99%
“…At least one nanomaterial-based biosensor exists for organophosphorus pesticides, using acetylcholinesterase and gold nanoparticles [37]. BLG is amenable to nanoparticle formation [38], as well as to reengineering to bind selected ligands, such as a dopamine antagonist [39]. BLG has the additional property of being able to bind different ligands with good affinity with a single binding site, which can be exploited in biosensor design.…”
Section: Discussionmentioning
confidence: 99%
“…Although Davis and Dubos (1947) noted that βLg bound about half as much oleic acid as serum albumin, it was Groves et al (1951) who showed that 2 mol/mol of sodium dodecyl sulfate not only bound but had a stabilizing effect on thermal denaturation. Since then, a large number of ligands for βLg has been identified and that number is still increasing ( Sawyer, 2003 ; Tromelin and Guichard, 2006 ; Cherrier et al, 2013 ; Le Maux et al, 2014 ; Loch et al, 2015 , 2018 ). To date, the only definitive ligand binding site is within the central calyx despite there being several experimental studies indicating that alternative sites may exist ( Frapin et al, 1993 ; Dufour et al, 1994 ; Lange et al, 1998 ; Narayan and Berliner, 1998 ; Lübke et al, 2002 ; Yang et al, 2008 , 2009 ; Edwards and Jameson, 2020 ).…”
Section: β-Lactoglobulinmentioning
confidence: 99%
“…Crystals of this variant had unusual orthorhombic symmetry P2 1 2 1 2 1 (Table S2 at https://ojs.ptbioch.edu.pl/index.php/abp/) with protein dimer in the asymmetric unit. The binding pocket in the I56F variant (Bonarek et al, 2020) and its derivatives I56F/L39A and I56F/L39A/M107F (Loch et al, 2018) has a permanently reduced length. The large side chain of phenylalanine in position 56 prevents aliphatic ligands and tetracaine from binding in the modified binding pocket.…”
Section: Structure Of L39k and F105a Mutantsmentioning
confidence: 99%
“…Human lipocalins are usually modified by randomization of flexible loops surrounding β-barrel to create highly specific proteins with potential medical applications called Anticalins (Rothe & Skerra, 2018). In our studies, local site-directed mutagenesis was used to change the geometry of the BLG ligand binding pocket and therefore change its ligand preferences (Loch et al, 2018;Bonarek et al, 2020). Detailed physicochemical characteristics of seven new lactoglobulin mutants (L39Y, I56F, L58F, V92F, V92Y, F105L, and M107L) as well as crystal structure of five of these variants and their complexes with selected fatty acids have been published elsewhere (Bonarek et al, 2020).…”
Section: Introductionmentioning
confidence: 99%